Search results
Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
LA Times via Yahoo News· 7 months agoDr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in...
Nobel Prize Awarded to mRNA Pioneers Who Paved the Way for COVID-19 Vaccines
Time via Yahoo News· 7 months agoIt was an unlikely collaboration, and it began in an unlikely place, but the partnership that...
With old-school technology, can Novavax win over COVID vaccine skeptics?
LA Times via Yahoo News· 2 years agoA vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London....
How the COVID vaccine became a factor in the sale of meat
Deseret News via Yahoo News· 2 months agoOn the website of the meat-by-mail company Good Ranchers, potential customers learn about the...
Two Penn scientists awarded Nobel Prize in Medicine for work with mRNA, COVID-19 vaccines
USA TODAY via Yahoo News· 7 months agoTwo scientists who met at a copy machine and worked for decades in obscurity were awarded the 2023...
Pfizer 'surprised' by Moderna COVID-19 vaccine patent lawsuit
Yahoo Finance via AOL· 2 years agoModerna (MRNA) said Friday it is suing Pfizer and BioNTech (PFE/BNTX), alleging the rival drug...
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Moderna MRNA to beat expectations when it reports first-quarter 2023 results on May 4,...
Is Moderna a Good Stock to Buy Right Now?
Motley Fool· 1 year agoShares of Moderna (NASDAQ: MRNA) recently shot higher in response to surprisingly positive results from a clinical trial with a cancer drug candidate. In...
‘Deep Tech’ has become one of the most powerful use cases for A.I. in business. Here are 3 keys to...
Fortune via Yahoo Finance· 2 years agoIn early 2020, when scientists rushed to develop a vaccine to take on the SARS-CoV-2 coronavirus...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 weeks agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...